REGEN BIOPHARMA, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -2,957.0% | -7,750.6% |
| FY2017 | — | -2,282.6% | -5,308.2% |
| FY2018 | — | -1,425.8% | -4,715.2% |
| FY2019 | — | -688.0% | -2,384.7% |
| FY2020 | — | -190.3% | 3,104.0% |
| FY2021 | — | -328.1% | -11,055.4% |
| FY2022 | — | -270.6% | 1,946.8% |
| FY2023 | — | -542.8% | 913.8% |
| FY2024 | — | -176.4% | -282.5% |
| FY2025 | — | -143.1% | -538.8% |